Structures by: Şahin E.
Total: 58
C18H12N2O2
C18H12N2O2
Organic & biomolecular chemistry (2016) 14, 31 7490-7494
a=4.7369(4)Å b=24.686(2)Å c=12.2902(13)Å
α=90° β=99.492(3)° γ=90°
(<i>E</i>)-4-{[2-(4-Hydroxybenzoyl)hydrazin-1-ylidene]methyl}pyridin-1-ium nitrate
C13H12N3O2,NO3
Acta Crystallographica Section E (2018) 74, 3 323-327
a=8.335(3)Å b=13.929(5)Å c=12.184(4)Å
α=90.00° β=95.902(10)° γ=90.00°
3-(4-Chlorophenyldiazenyl)-1-methyl-2-phenyl-1H-indole
C21H16ClN3
Acta Crystallographica Section E (2006) 62, 6 o2108-o2110
a=8.0836(10)Å b=27.952(4)Å c=30.483(3)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-5-(p-nitrophenylsulfonyl)-1,3-thiazole
C9H7N3O4S2
Acta Crystallographica Section E (2006) 62, 7 o2634-o2636
a=8.6310(2)Å b=12.4943(3)Å c=11.4911(4)Å
α=90.00° β=110.874(2)° γ=90.00°
N-{4-[(2-Phenyl-1H-indol-3-yl)diazenyl]phenyl}acetamide
C22H18N4O
Acta Crystallographica Section E (2006) 62, 8 o3492-o3494
a=5.996(5)Å b=14.786(5)Å c=20.531(5)Å
α=90° β=90° γ=90°
6-[3-Phenyl-5-(trifluoromethyl)pyrazol-1-yl]pyridazin-3(2H)-one
C14H9F3N4O1
Acta Crystallographica Section E (2006) 62, 2 o446-o448
a=7.603(2)Å b=8.079(2)Å c=11.202(4)Å
α=82.97(3)° β=74.84(3)° γ=84.95(3)°
1-Methyl-2-phenyl-3-(thiadiazol-2-yldiazenyl)-1H-indole
C17H13N5S
Acta Crystallographica Section E (2007) 63, 1 o148-o150
a=8.0288(2)Å b=17.3757(3)Å c=11.1899(3)Å
α=90.00° β=104.4222(14)° γ=90.00°
1,2-Dimethyl-3-(thiazol-2-yldiazenyl)-1H-indole
C13H12N4S
Acta Crystallographica Section E (2007) 63, 1 o351-o353
a=8.7257(2)Å b=10.3070(2)Å c=14.4948(6)Å
α=83.828(6)° β=88.489(6)° γ=79.757(5)°
Trans-N,N'-Bis(3-methoxysalicylidene)-1,2-cyclohexanediamine
C22H26N2O4
Acta Crystallographica Section E (2007) 63, 2 o644-o645
a=10.090(5)Å b=10.970(5)Å c=11.678(5)Å
α=115.254(5)° β=112.401(5)° γ=95.258(5)°
1-Methyl-2-phenyl-3-(5-ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1H-indole
C19H17N5S
Acta Crystallographica Section E (2007) 63, 2 o568-o570
a=10.7629(14)Å b=10.0115(8)Å c=16.568(2)Å
α=90.00° β=99.664(6)° γ=90.00°
6-Amino-1,3-dimethyl-5-(4-methylthiazol-2-yldiazenyl)uracil
C10H12N6O2S
Acta Crystallographica Section E (2007) 63, 2 o571-o573
a=9.3604(3)Å b=10.3052(3)Å c=13.2638(5)Å
α=90.00° β=93.391(2)° γ=90.00°
1,2-Dibromo-5-(4-tolylsulfonyl)-2,2a,4a,5,7a,7b-hexahydro-1H-7-oxa-5- azacyclobuta[e]inden-6-one
C16H15Br2NO4S
Acta Crystallographica Section E (2007) 63, 5 o2464-o2464
a=10.8513(4)Å b=6.0019(3)Å c=26.7246(7)Å
α=90.000000° β=90.232(2)° γ=90.000000°
<i>O</i>-Butyl S-(1,1,3-trioxobenz[<i>d</i>]isothiazol-2-yl)methyl dithiocarbonate
C13H15NO4S3
Acta Crystallographica Section E (2007) 63, 6 o2974-o2974
a=8.8191(3)Å b=13.4997(2)Å c=14.7531(2)Å
α=70.270(3)° β=85.255(5)° γ=89.696(5)°
1-Methyl-3-(5-methylthiazol-2-yldiazenyl)-2-phenyl-1H-indole
C19H16N4S
Acta Crystallographica Section E (2007) 63, 7 o3281-o3282
a=9.2514(7)Å b=9.2745(5)Å c=11.0971(6)Å
α=106.2590(10)° β=106.542(2)° γ=103.337(2)°
4-[(<i>E</i>)-Phenyldiazenyl]-2-[(<i>E</i>)-phenyliminomethyl]phenol
C19H15N3O
Acta Crystallographica Section E (2007) 63, 8 o3637-o3637
a=10.336(5)Å b=12.585(5)Å c=12.384(5)Å
α=90° β=100.497(5)° γ=90°
(1Z,2E)-1-(3,5-Dimethyl-1H-pyrazol-1-yl)-1,2-ethanedione dioxime
C7H10N4O2
Acta Crystallographica Section E (2007) 63, 8 o3601-o3601
a=9.7598(5)Å b=9.8572(6)Å c=9.8140(7)Å
α=90° β=104.254(3)° γ=90°
2,2'-[1,1'-(Propane-2,2-diyldiimino)diethylidene]diphenol
C21H30N2O2
Acta Crystallographica Section E (2007) 63, 9 o3770-o3770
a=11.4232(3)Å b=10.1303(3)Å c=18.4399(4)Å
α=90.000(5)° β=107.753(5)° γ=90.000(5)°
2-Hydroxyimino-1-phenylethanone thiosemicarbazone monohydrate
C9H10N4OS,H2O
Acta Crystallographica Section E (2008) 64, 3 o623-o624
a=28.5615(3)Å b=4.6805(3)Å c=22.0977(4)Å
α=90.00° β=127.24(2)° γ=90.00°
<i>N</i>-(2,6-Dimethyl-3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2-hydroxy-2,2- diphenylacetamide
C24H28N2O3S
Acta Crystallographica Section E (2008) 64, 10 o1919
a=9.4942(4)Å b=20.6765(5)Å c=12.0052(4)Å
α=90° β=105.063(2)° γ=90°
2-(2,2-Dimethoxyethyl)-3-oxo-1,2,3,4,5,6-hexahydro-1,5-methano- 7H-azocino[4,3-b]indole
C18H22N2O3
Acta Crystallographica Section E (2007) 63, 7 o3268-o3268
a=10.0347(4)Å b=8.4616(7)Å c=20.1168(9)Å
α=90.00° β=103.750(3)° γ=90.00°
1-Methyl-2-phenyl-1H-indole
C15H13N
Acta Crystallographica Section E (2007) 63, 4 o1963-o1964
a=8.19570(10)Å b=15.8652(3)Å c=17.1653(3)Å
α=90.0° β=90.0° γ=90.0°
3-[5,6-Dimethyl-1,3-benzothiazol-2-yl)diazenyl]-1-methyl-2-phenyl- 1<i>H</i>-indole
C24H20N4S
Acta Crystallographica Section E (2007) 63, 7 o3170-o3170
a=13.171(5)Å b=9.815(2)Å c=17.257(4)Å
α=90° β=112.31(2)° γ=90°
C17H15N3O2
C17H15N3O2
Acta Crystallographica Section E (2006) 62, 9 o4130-o4131
a=10.5985(3)Å b=11.2970(2)Å c=12.7652(3)Å
α=90.00° β=107.6970(10)° γ=90.00°
5-[(5-Methylthiazol-2-yl)diazenyl]pyrimidine-2,4,6(1H,3H,5H)-trione
C8H7N5O3S
Acta Crystallographica Section E (2007) 63, 3 o1506-o1508
a=13.092(2)Å b=7.0989(9)Å c=12.913(2)Å
α=90.00° β=116.321(7)° γ=90.00°
3-(6-Methoxybenzothiazol-2-yldiazenyl)-1-methyl-2-phenyl-1<i>H</i>-indole
C23H18N4OS
Acta Crystallographica Section E (2007) 63, 6 o2837-o2839
a=7.3672(2)Å b=17.9326(5)Å c=15.0284(3)Å
α=90.00° β=99.70(2)° γ=90.00°
2-Hydroxy-N-(3-oxo-1-thia-4-azaspiro[4.5]dec-4-yl)-2,2-diphenylacetamide
C22H24N2O3S
Acta Crystallographica Section E (2007) 63, 8 o3379-o3380
a=12.1676(2)Å b=9.3050(2)Å c=17.9081(3)Å
α=90° β=95.4236(11)° γ=90°
3-(5-Methylsulfanyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-methyl-1H-indole
C13H13N5S2
Acta Crystallographica Section E (2007) 63, 5 o2263-o2264
a=7.2739(2)Å b=13.4818(2)Å c=14.7373(4)Å
α=78.488(4)° β=87.707(5)° γ=85.551(5)°
1,3-Dimethyl-5-(thiazol-2-yldiazenyl)pyrimidine-2,4,6(1H,3H,5H)-trione
C9H9N5O3S
Acta Crystallographica Section E (2006) 62, 12 o5855-o5857
a=15.3047(5)Å b=7.4568(2)Å c=19.5403(5)Å
α=90.00° β=92.152(2)° γ=90.00°
Ethyl [2-(2-phenyl-1H-indol-3-yldiazenyl)-1,3-thiazol-4-yl]acetate
C21H18N4O2S
Acta Crystallographica Section E (2006) 62, 9 o3835-o3837
a=10.61110(10)Å b=10.5040(2)Å c=17.3345(2)Å
α=90.00° β=100.2480(10)° γ=90.00°
Ethyl 2-{[(2-phenyl-1H-indol-3-yl)diazenyl]thiazol-4-yl}acetate
C22H20N4O2S
Acta Crystallographica Section E (2006) 62, 12 o5488-o5489
a=9.5545(3)Å b=16.5418(2)Å c=13.1399(3)Å
α=90.00° β=101.07(11)° γ=90.00°
3-(5-Ethyl-1,3,4-thiadiazol-2-yldiazenyl)-1,2-dimethyl-1H-indole
C14H15N5S1
Acta Crystallographica Section E (2007) 63, 5 o2265-o2266
a=8.18790(10)Å b=8.2359(2)Å c=10.5343(3)Å
α=92.560(10)° β=96.66(2)° γ=92.31(3)°
Diaquabis(4-chlorobenzoato-κ<i>O</i>)bis-(<i>N</i>,<i>N</i>- diethylnicotinamide-κ<i>N</i>)zinc(II)
C34H40Cl2N4O8Zn
Acta Crystallographica Section E (2007) 63, 8 m2191-m2191
a=7.3570(2)Å b=8.6887(10)Å c=15.9114(10)Å
α=85.047(5)° β=78.476(5)° γ=67.321(4)°
C13H13N3O
C13H13N3O
Acta Crystallographica Section C (2003) 59, 4 o192-o193
a=5.5633(16)Å b=10.4599(11)Å c=20.314(4)Å
α=90.00° β=95.51(2)° γ=90.00°
(1SR,2SR,3SR,4RS,5RS,6RS,7SR,8RS)-7,8-Dichlorobicyclo[4.2.0]octa-2,3,4,5-tetrayl tetraacetate
C16H20Cl2O8
Acta Crystallographica Section C (2006) 62, 7 o432-o434
a=8.9489(5)Å b=11.0230(8)Å c=11.2885(7)Å
α=111.427(2)° β=98.2810(10)° γ=108.8340(10)°
Diaquabis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>^1^)bis(4- formylbenzoato-κ<i>O</i>)cobalt(II)
C36H42CoN4O10
Acta Crystallographica Section E (2009) 65, 4 m389-m390
a=7.2962(2)Å b=8.6863(3)Å c=15.9453(5)Å
α=85.433(2)° β=78.608(3)° γ=68.022(2)°
5,6-Diphenylpyrazine-2,3-dicarbonitrile
C18H10N4
Acta Crystallographica Section E (2009) 65, 9 o2225
a=9.2195(2)Å b=7.2837(2)Å c=21.5507(5)Å
α=90.00° β=101.1080(10)° γ=90.00°
Tetraaquabis(nicotinamide-κ<i>N</i>^1^)cobalt(II) bis(2-fluorobenzoate)
C12H20CoN4O62,2(C7H4FO2)
Acta Crystallographica Section E (2009) 65, 3 m341-m342
a=7.2913(2)Å b=7.4522(4)Å c=14.4853(5)Å
α=82.160(2)° β=77.275(3)° γ=63.740(3)°
Rac-3,4-<i>trans</i>-Dichloro-1,2,3,4-tetrahydro-2-naphthyl acetate
C12H12Cl2O2
Acta Crystallographica Section E (2008) 64, 12 o2269
a=12.931(5)Å b=12.478(5)Å c=7.441(4)Å
α=90° β=101.040(5)° γ=90°
Diaquabis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>^1^)bis(4- formylbenzoato-κ<i>O</i>)nickel(II)
C36H42N4NiO10
Acta Crystallographica Section E (2009) 65, 3 m326-m327
a=7.2909(2)Å b=8.6883(3)Å c=15.9037(4)Å
α=85.034(5)° β=78.576(4)° γ=67.594(3)°
2,3-Dibromo-1-[4-(2,3-dibromo-4,5-dimethoxybenzyl)-2,5-dimethoxybenzyl]- 4,5-dimethoxybenzene
C26H26Br4O6
Acta Crystallographica Section E (2010) 66, 11 o3029
a=11.193(5)Å b=9.645(4)Å c=13.212(5)Å
α=90.000° β=107.125(5)° γ=90.000°
1-Ethyl-<i>N</i>'-[(<i>E</i>)-4-hydroxybenzylidene]-7-methyl-4-oxo-1,4- dihydro-1,8-naphthyridine-3-carbohydrazide
C19H18N4O3
Acta Crystallographica Section E (2009) 65, 4 o860-o861
a=7.6437(2)Å b=13.3290(2)Å c=17.2212(4)Å
α=90.000000° β=98.1745(14)° γ=90.000000°
Diaquabis(<i>N</i>,<i>N</i>-diethylnicotinamide-κ<i>N</i>^1^)bis(4- formylbenzoato-κ<i>O</i>^1^)manganese(II)
C36H42MnN4O10
Acta Crystallographica Section E (2009) 65, 3 m324-m325
a=7.3266(2)Å b=8.6618(2)Å c=16.0687(3)Å
α=86.381(8)° β=78.272(7)° γ=68.618(6)°
<i>rac</i>-(2<i>R*</i>,3<i>S</i>*,5<i>S*</i>,6<i>R*</i>,7<i>S*</i>, 8<i>S</i>*)-7,8-Dichlorobicyclo[2.2.2]octane-2,3,5,6-tetrayl tetraacetate
C16H20Cl2O8
Acta Crystallographica Section E (2009) 65, 3 o526-o527
a=10.1061(3)Å b=13.3383(4)Å c=14.2229(3)Å
α=90° β=90.189(2)° γ=90°
2,4-Di-<i>tert</i>-butyl-6-[(2,5-difluorophenyl)iminomethyl]phenol
C21H25F2NO
Acta Crystallographica Section E (2009) 65, 11 o2786
a=6.423(5)Å b=17.386(5)Å c=17.337(5)Å
α=90.000(5)° β=90.319(5)° γ=90.000(5)°
<i>N</i>'-[(<i>E</i>)-Benzylidene]-1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carbohydrazide
C19H18N4O2
Acta Crystallographica Section E (2009) 65, 12 o3152-o3153
a=7.16420(10)Å b=8.83830(10)Å c=14.4560(2)Å
α=82.624(6)° β=85.454(7)° γ=68.594(5)°
2-Ethyl-6,6-ethylenedisulfanediyl-7-methoxymethyl-1,2,3,4,5,6-hexahydro-1,5- methanoazocino[4,3-<i>b</i>]indol-3-one
C20H24N2O2S2
Acta Crystallographica Section E (2010) 66, 2 o328
a=14.0409(3)Å b=6.8916(2)Å c=20.2820(4)Å
α=90.00° β=109.783(2)° γ=90.00°
3-Phenyldiazenyl-1,2-dimethyl-1<i>H</i>-indole
C16H15N3
Acta Crystallographica Section E (2010) 66, 9 o2311
a=16.3442(3)Å b=10.2713(2)Å c=16.5312(3)Å
α=90° β=104.264(3)° γ=90°
(3a<i>R</i>,4<i>S</i>,7<i>R</i>,7a<i>S</i>)-2-Phenyl-4-propyl-\ 3a,4,7,7a-tetrahydro-1<i>H</i>-4,7-epithioisoindole-1,3-dione 8-oxide
C17H17NO3S
Acta Crystallographica Section E (2011) 67, 5 o1085-o1086
a=7.7712(3)Å b=10.8413(3)Å c=18.9762(4)Å
α=90.00° β=90.00° γ=90.00°
<i>catena</i>-Poly[[[bis(4-ethylbenzoato-κ^2^<i>O</i>,<i>O</i>)lead(II)]- μ-nicotinamide-κ^2^<i>N</i>^1^:<i>O</i>] monohydrate]
C24H24N2O5Pb,H2O
Acta Crystallographica Section E (2011) 67, 8 m1057-m1058
a=7.8093(2)Å b=9.7950(3)Å c=16.9380(5)Å
α=90.772(2)° β=91.256(2)° γ=106.916(4)°
3,4-Dimethylpyrano[2,3-<i>c</i>]pyrazol-6(2<i>H</i>)-one
C8H8N2O2
Acta Crystallographica Section E (2012) 68, 4 o1217
a=13.6219(3)Å b=6.8766(2)Å c=16.2369(4)Å
α=90.00° β=96.091(2)° γ=90.00°
C22H22N4O5
C22H22N4O5
The Journal of Organic Chemistry (2009) 74, 24 9452-9459
a=9.277(5)Å b=10.250(5)Å c=11.192(5)Å
α=83.586(5)° β=88.685(5)° γ=76.696(5)°
C16H21N3O2
C16H21N3O2
The Journal of Organic Chemistry (2009) 74, 24 9452-9459
a=8.2049(2)Å b=8.91260(10)Å c=11.02020(10)Å
α=72.415(4)° β=87.435(4)° γ=85.548(5)°
C16H22O9
C16H22O9
Journal of Organic Chemistry (2012) 77, 1244-1250
a=8.8325(4)Å b=14.1648(4)Å c=14.7778(5)Å
α=90.0000(0)° β=99.154(5)° γ=90.000(5)°
C16H22O9
C16H22O9
Journal of Organic Chemistry (2012) 77, 1244-1250
a=17.04(2)Å b=8.094(12)Å c=26.81(3)Å
α=90° β=90° γ=90°
C26H30O5
C26H30O5
Journal of Organic Chemistry (2007) 72, 3353-3359
a=17.156(3)Å b=11.5476(18)Å c=22.209(3)Å
α=90.00° β=90.00° γ=90.00°
C18H20O3
C18H20O3
Journal of Organic Chemistry (2007) 72, 3353-3359
a=17.283(2)Å b=22.136(3)Å c=7.4999(9)Å
α=90.00° β=90.00° γ=90.00°
C21H23N1O4
C21H23N1O4
Journal of Organic Chemistry (2007) 72, 3353-3359
a=9.7608(5)Å b=20.7728(8)Å c=9.7588(5)Å
α=90° β=113.587(10)° γ=90°
C13H15NO3S
C13H15NO3S
Zeitschrift für Kristallographie - New Crystal Structures (2002) 217, 4 529-530
a=4.9524(11)Å b=22.001(3)Å c=11.961(2)Å
α=90.00° β=94.031(16)° γ=90.00°